The Effect of Trendelenburg Position on the Ultrasonographic Airway Measurements
Launched by ANKARA CITY HOSPITAL BILKENT · Feb 3, 2022
Trial Information
Current as of May 08, 2025
Unknown status
Keywords
ClinConnect Summary
In the preoperative period, age, body weight, height, neck circumference, comorbidities (Charlson comorbidity index), ASA score, Modified mallampati classification, STOP-BANG risk score will be recorded.Intraoperative monitorization data will be recorded.
Following ultrasonographic airway measurements will be performed preoperatively and postoperatively.
A low frequency convex probe will be used for ultrasonography. To achieve a fixed position of the tongue, patients will be placed supine without a pillow, with their head fully tilted back, and asked to hold their tongue loosely, without ...
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Robotic Laparoscopic Prostatectomy
- • 2. ASA I-II-III-IV risk group -
- Exclusion Criteria:
- • 1. contraindication of trendelenburg position,
- • 2. history of maxillofacial deformity, tumor or trauma,
- • 3. history of difficult airway,
- • 4. decompensated cardiac, respiratory, hepatic, renal disease,
- • 5. with cervical spine fracture
- • 6. patient refusal -
About Ankara City Hospital Bilkent
Ankara City Hospital Bilkent is a leading healthcare institution in Turkey, dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. Equipped with state-of-the-art facilities and a multidisciplinary team of experienced professionals, the hospital fosters a collaborative environment for conducting rigorous scientific investigations. Its commitment to ethical standards and patient safety ensures that all clinical trials are conducted with the highest level of integrity, ultimately contributing to the development of new therapies and enhancing the quality of care provided to patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Trial Officials
betül güven aytaç
Principal Investigator
ankara ch bilkent
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials